Dry Eye Treatment Devices Market to Witness Tremendous Growth and Expansion by 2028

 Dry Eye Treatment Devices Market Growth & Trends

The global dry eye treatment devices market size is estimated to reach USD 414.2 million by 2028, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 6.3% over the forecast period. The increasing demand for targeted, non-invasive, faster, and patient compliant treatment methods to alleviate dry eye symptoms are the factors expected to drive the market growth during the forecast period.

The rising incidence of causative risk factors such as over usage of contact lenses, prolonged exposure to digital screens, diabetes, glaucoma, and Sjogren's syndrome globally is anticipated to propel the growth of the market. For instance, Americans are estimated to spend an average time of more than 10 hours a day at visual display terminals.

The increasing number of clinical and research activities conducted to evaluate the safety and efficacy of advanced dry eye treatment devices such as IPL and BBL will boost market growth. The application of these advanced technologies in eye care is at a nascent stage in many countries, thereby clinical evidence is essential to increase provider confidence over its acceptance. Besides, clinical studies of these technologies are showing promising results in comparison with conventional treatment methods in dry eye treatment.

The availability of alternative treatment, high cost of IPL/BBL treatment, numerous contraindications associated with IPL, and lack of an efficient health insurance policy in several countries are the factors rendering the growth of the dry eye treatment devices market. For instance, the treatment of dry eye syndrome using intense pulsed light (IPL) is not covered under the NHS, a major provider of healthcare service in the U.K.

Request a free sample copy or view report summary: Dry Eye Treatment Devices Market Report

Dry Eye Treatment Devices Market Report Highlights

• The MGX technology held the largest market share in 2020 owing to the factors such as frequent product launches, cost-effectiveness, and improving accessibility
• IPL and Combination (IPL+MGX) technologies are expected to grow at the fastest rate during the forecast period due to the factors such as the development of economical and compact-sized IPL devices having versatility in treating skin tone of all types have boosted its installation rate in clinics and ophthalmic centers
• North America held the largest market share in the market and is anticipated to maintain its dominance over the forecast period, attributable to the growing prevalence of dry eye disease, increasing R&D expenditure, and many ophthalmology trade conferences and expos conducted in the U.S. and Canada
• Some of the prominent companies are Lumenis; ESW Vision; Johnson & Johnson Services, Inc.; MiBo Medical Group; Alcon; and Sight Sciences

Access Press Release@ https://www.grandviewresearch.com/press-release/global-dry-eye-treatment-devices-market

Dry Eye Treatment Devices Market Segmentation

Grand View Research has segmented the dry eye treatment devices market based on technology and region:

Dry Eye Treatment Devices Technology Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Broadband light (BBL)
• Intense Pulsed Light (IPL)
• Meibomian Gland Expression (MGX)
• Combination (MGX+IPL)

Dry Eye Treatment Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of the Dry Eye Treatment Devices Market

• MiBo Medical Group
• Sight Sciences
• Lumenis
• ESW Vision
• Johnson & Johnson Vision Care
• Alcon, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Transplantation Market Will See Strong Expansion Through 2028: Grand View Research Inc.

 Transplantation Market Growth & Trends

The global transplantation market size is expected to reach USD 26.5 billion by 2028, growing at a CAGR of 11.5%, according to a new report by Grand View Research, Inc. Growing incidence of organ failure has resulted in high demand for transplantation procedures, which is boosting the market growth. Rising demand for transplant products, such as tissue products, immunosuppressants, and organ preservation solutions, is also a major factor driving the market. Many biotechnology and medical device companies are concentrating on the development of advanced transplant products for the management of organ failure.

Thus, technological advancement and the development of novel & improved transplant products, such as surgical instruments, have majorly contributed to the expansion of the market. In addition, the introduction of advanced tissue products, such as DeNovo NT Graft, Chondrofix Osteochondral Allograft, and DuraMatrix Collagen Dura Substitute Membrane, provides higher benefits during treatment. Furthermore, computerized support systems with advanced systems and software allow easy & effective maintenance of tissues. Thus, the availability of such advanced techniques supports market growth.

Request a free sample copy or view report summary: Transplantation Market Report

Transplantation Market Report Highlights

• The tissue products segment accounted for the largest revenue share in 2020 due to increased demand for tissue and organ transplant procedures
• The tissue products segment is expected to expand further at a significant CAGR from 2021 to 2028 owing to the advancements in transplantation products
• The tissue transplant segment held the largest revenue share in 2020 on account of the high demand for tissue transplant procedures worldwide
• The transplant centers segment is projected to record the fastest CAGR during the forecast period owing to the rising popularity of these centers for transplant procedures
• The hospitals segment dominated the market, in terms of revenue share, in 2020 owing to a large number of transplant procedures performed in hospitals
• North America was the leading regional market in 2020 and is projected to maintain its dominance during the forecast period owing to the presence of well-developed healthcare infrastructure in the region
• The presence of a large number of research laboratories, biotechnology, and medical device companies inNorth America is also one of the key factors contributing to the region’s growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-transplantation-market

Transplantation Market Segmentation

Grand View Research has segmented the global transplantation market on the basis of product type, application type, end-use, and region:

Transplantation Product Type Outlook (Volume, Units; Revenue, USD Billion, 2016 - 2028)

• Tissue Products
• Immunosuppressive Drugs
• Preservation Solutions

Transplantation Application Type Outlook (Volume, Units; Revenue, USD Billion, 2016 - 2028)

• Organ Transplant
• Tissue Transplant

Transplantation End-use Outlook (Volume, Units; Revenue, USD Billion, 2016 - 2028)

• Hospitals
• Transplant Centers
• Others

Transplantation Regional Outlook (Volume, Units; Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Transplantation Market

• Stryker Corp.
• Medtronic PLC
• AbbVie Inc.
• Zimmer Biomet
• Novartis International AG
• 21st Century Medicine
• Biolife Solutions
• Teva Pharmaceutical
• Veloxis Pharmaceuticals

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Clinical Trial Imaging Market Latest Trends, Industry Growth And Forecast To 2028: Grand View Research Inc.

 Clinical Trial Imaging Market Growth & Trends

The global clinical trial imaging market size is expected to reach USD 1.4 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.1% from 2021 to 2028. The increasing R&D spending to develop new drugs and therapies to treat chronic diseases is propelling the market growth.

Clinical trial imaging makes use of imaging technology in clinical trials for seeing the interior parts of the body. The images obtained from clinical trial imaging are used to examine drug activity. Clinical trial imaging provides rapid, detail, and precise screening. The use of clinical trial imaging has rapidly increased in all phases of the clinical trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.

The clinical trial design includes selecting patient population, stratification based on biomarkers, different methods for allocation treatments, choosing efficient and reliable endpoints and validation of surrogate endpoints, calculating sample size, trial simulations, adaptive trial set-up, statistical and interim analysis, and assisting clients to deal with regulatory authorities, such as EMA and FDA, to discuss study design or defend study results.

Market players provide analytical testing services, pharmacokinetic, reading, and pharmacodynamics services for enhanced clinical development. IXICO offers advanced technologies for catalyzing clinical trials in neuroscience. Imaging biomarkers by the company help in measuring the safety and effectiveness of therapies used for neuroimaging. Imaging biomarkers are effective in radiological reads. This provides a radiological reading of MRI scans for central neuro to enhance the assessment of ongoing monitoring of drug safety and subject eligibility.

Request a free sample copy or view report summary: Clinical Trial Imaging Market Report

Clinical Trial Imaging Market Report Highlights

• Based on service, project and data management services held the largest share in 2020 due to the growing requirement of data management and workflow for clinical trial imaging
• Operational imaging services held a significant share in 2020. They include imaging modalities such as MRI, CT scan, X-ray, ultrasound, OCT, PET, and SPECT. CT scan modality is gaining popularity due to its non-invasive nature and its ability to provide detailed information about the disease for enhanced treatment
• The others application segment held the largest share in 2020. This segment includes oncology, neurology, and musculoskeletal. Market players such as ICON, Bioclinica, Navitas Life Sciences, and Paraxel International are developing their clinical trial imaging services for these applications
• By end-use, CROs held the largest share in 2020 due to increasing investments in the field of research and development and snowballing outsourcing activities by the pharmaceutical and biotechnology companies to cut down the cost and time and patent expiration
• North America dominated the market in 2020 due to the increasing geriatric population, rising chronic diseases, and growing demand for treatment options

Access Press Release@ https://www.grandviewresearch.com/press-release/global-clinical-trial-imaging-market

Clinical Trial Imaging Market Segmentation

Grand View Research has segmented the global clinical trial imaging market based on service, application, end-use, and region:

Clinical Trial Imaging Service Outlook (Revenue, USD Million, 2016 - 2028)  

• Clinical Trial Design and Consultation Services
• Reading and Analytical Services
• Operational Imaging Services
  • Computed Tomography (CT) Scan
  • MRI (Magnetic Resonance Imaging)
  • X-Ray
  • Ultrasound
  • Optical Coherence Tomography (OCT)
  • Others
• System and Technology Support Services
• Project and Data Management

Clinical Trial Imaging Application Outlook (Revenue, USD Million, 2016 - 2028)      

• NASH
• CKD
• Diabetes
• Cardiovascular Diseases
• Others

Clinical Trial Imaging End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Biotechnology and Pharmaceutical companies
• Medical Devices Manufacturers
• Academic and Government Research Institutes
• Contract Research Organizations (CROs)
• Others

Clinical Trial Imaging Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • India
  • China
  • Japan
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Clinical Trial Imaging Market

• Parexel International Corporation
• Intrinsic Imaging
• Bioclinica Inc.
• Icon PLC
• Radiant Sage
• Navitas Life Sciences
• Resonance Health
• IXICO PLC
• Medpace

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sternal Closure Systems Market Will See Strong Expansion Through 2028: Grand View Research Inc.

 Sternal Closure Systems Market Growth & Trends

The global sternal closure systems market size is expected to reach USD 3.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.6% from 2021 to 2028. The market is driven by the growing number of surgeries undertaken to treat complex cardiovascular problems. For instance, according to the data published by the Centers for Disease Control and Prevention (CDC), around 30.3 million or 12.1% of U.S. adults were diagnosed with heart disease in 2018.

The National Health Interview Survey conducted by CDC in 2016 concluded that 28.1 million people were diagnosed with heart-related disorders including, valvular heart disease, cardiac arrest. Moreover, technological advancements such as Talon systems, double sternal wires, and favorable reimbursement criteria would propel growth in the near future.

Mergers and acquisitions, new product development, and geographical expansion are key sustainability strategies adopted by players in the market. For instance, in December 2020, Zimmer Biomet Holdings Inc., acquired A&E Medical Corporation to gain access to its product portfolio, ensuring long-term growth.

Request a free sample copy or view report summary: Sternal Closure Systems Market Report

Sternal Closure Systems Market Report Highlights

• North America dominated the market in 2020, attributed to the presence of a large number of players and high competitive rivalry in the market
• By product, the closure devices segment held major shares of the market in 2020, owing to the introduction of technologically advanced clips and wires globally and favorable reimbursement regulations offer by developed regions such as North America and Europe
• By procedure, the median sternotomy segment dominated the market in 2020, as it is among the frequently performed osteotomies worldwide
• By material, the PEEK segment is anticipated to post significant growth over the coming years due to several benefits offered by the material, including biocompatibility, chemical resistance, end-product purity, high-temperature resistance, and thermoformable nature

Access Press Release@ https://www.grandviewresearch.com/press-release/global-sternal-closure-systems-market

Sternal Closure Systems Market Segmentation

Grand View Research has segmented the global sternal closure systems market based on product, procedure, material, and region:

Sternal Closure Systems Product Outlook (Revenue, USD Million, 2016 - 2028)

• Closure Devices
  • Wires
  • Plates and Screws
  • Clips
  • Cables
• Bone Cement

Sternal Closure Systems Material Outlook (Revenue, USD Million, 2016 - 2028)

• Titanium
• Polyether Ether Ketone (PEEK)
• Stainless Steel
• Others

Sternal Closure Systems Procedure Outlook (Revenue, USD Million, 2016 - 2028)

• Median Sternotomy
• Hemisternotomy
• Bilateral Thoracosternotomy
• Others

Sternal Closure Systems Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

List of Key Players of Sternal Closure Systems Market

• Zimmer Biomet
• Johnson & Johnson
• Braun Melsungen AG
• Orthofix Holdings, Inc.
• GE Healthcare
• KLS Martin Group
• A&E Medical Corporation
• Jace Medical, LLC
• Acute Innovations
• Abyrx, Inc.
• Kinamed Incorporated

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biopharmaceuticals Contract Manufacturing Market is Estimated to Register at a CAGR of 5.7% During The Forecast Period

 

Biopharmaceuticals Contract Manufacturing Market Growth & Trends

The global biopharmaceuticals contract manufacturing market size is expected to reach USD 25.1 billion by 2028 registering a CAGR of 5.7%, according to a new report by Grand View Research, Inc. Growing biopharmaceutical pipeline and lack of adequate manufacturing capabilities are two key factors that are driving partnership between large molecule manufacturers and Contract Manufacturing Organizations (CMOs). Contract manufacturers are engaged in broadening their service portfolio to meet the company demands with respect to regulatory standards and new services.

The reliance of companies on CMOs for the production of biologics and biosimilars is expected to rise over the forecast period as a consequence of changes adopted by the CMOs. This is evident through growing investment in collaborations of companies with CMOs as well as continuous efforts taken up for expanding the service portfolio.

The supply chain of biopharmaceuticals remained robust and was largely unaffected worldwide during the coronavirus outburst. Also, biopharmaceutical contract manufacturers are observing increased demand related to the Covid-19 vaccine and therapeutics. Thus, the future holds numerous opportunities for the global market. For instance, in 2020, AstraZeneca and Oxford Biomedica signed a one-year clinical and commercial supply agreement for the manufacturing of AstraZeneca’s Covid-19 vaccine candidate, AZD1222.

The future growth of CMOs is highly dependent on the promising opportunities offered by the biopharmaceutical industry, the bioprocessing industry, and the contract service industry. Expansion of fill-and-finish services and increasing robustness of venture capital investments for the life science sector are two important opportunities that are anticipated to drive the market. For instance, in 2019, Shanghai HaiHe Biopharma Co. Ltd. raised USD 146.6 million as venture capital for its large cancer drug portfolio, which they shall utilize along with their outsourcing partner Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

Request a free sample copy or view report summary: Biopharmaceuticals Contract Manufacturing Market Report

Biopharmaceuticals Contract Manufacturing Market Report Highlights

• Mammalian-based biopharmaceutical contract manufacturing captured the largest market share of over 59% in 2020 owing to the high penetration of mammalian expression system for biologics development
• Out of all the services offered in this market, process development contributed to the largest share in 2020 owing to high capital investment, especially in the downstream process
• The complexities associated with regulatory approval and good manufacturing practice pronounces the demand for the established contract manufacturers to ensure compliance with regulatory standards
• The biologics contract manufacturing segment dominated the global market in 2020 owing to higher demand for biologics production
• However, the biosimilar segment is estimated to register the fastest CAGR from 2021 to 2028 due to cost-saving advantages associated with biosimilars development
• North America was the dominant regional market in 2020 due to the presence of an effective regulatory framework for biologics development in the U.S.
• However, Asia Pacific is expected to emerge as the fastest-growing regional market from 2021 to 2028 owing to emerging countries, such as India and China, incorporating developments to sustain the competition
• Several international companies are seeking outsourcing of biopharmaceutical production to Asian countries owing to the continuous expansion of Asian CMOs that offer services at a less price, as compared to the service providers based in western countries

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biopharmaceuticals-contract-manufacturing-market

Biopharmaceuticals Contract Manufacturing Market Segmentation

Grand View Research has segmented the global biopharmaceuticals contract manufacturing market on the basis of source, service, product, and region:

Biopharmaceuticals Contract Manufacturing Source Outlook (Revenue, USD Million, 2016 - 2028)

• Mammalian
• Non-mammalian

Biopharmaceuticals Contract Manufacturing Service Outlook (Revenue, USD Million, 2016 - 2028)

• Process Development
  • Downstream
  • Upstream
• Fill & Finish Operations
• Analytical & QC Studies
• Packaging

Biopharmaceuticals Contract Manufacturing Product Outlook (Revenue, USD Million, 2016 - 2028)

• Biologics
  • Monoclonal Antibodies (MABs)
  • Recombinant Proteins
  • Vaccines
  • Antisense, RNAi, & Molecular Therapy
  • Others
• Biosimilars

Biopharmaceuticals Contract Manufacturing Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
• Asia Pacific
  • China
  • India
• Latin America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players in Biopharmaceuticals Contract Manufacturing Market

• Boehringer Ingelheim GmbH
• Lonza
• Inno Biologics Sdn Bhd
• Rentschler Biotechnologie GmbH
• JRS Pharma
• AGC Biologics
• ProBioGen
• Fujifilm Diosynth Biotechnologies U.S.A., Inc.
• Toyobo Co., Ltd.
• Samsung BioLogics
• Thermo Fisher Scientific, Inc.
• Binex Co., Ltd.
• WuXi Biologics
• AbbVie, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

3D Cell Culture Market is Growing at Significant Rate, 2028: Grand View Research Inc.

 3D Bioprinting Market Growth & Trends

The global 3D bioprinting market size is expected to reach USD 4.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.8% from 2021 to 2028. Rising cases of COVID-19 and increasing prevalence of chronic diseases are some of the major factors contributing towards market growth.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 12, 2021, more than 91.5 million cases of COVID-19 were reported globally, with more than 1,956,880 deaths, across the globe. This pandemic has fast tracked the development of vaccine and drug testing. There are currently more than 50 COVID-19 vaccine candidates in trials.

In the meantime, various 3D bioprinting companies are focused on research and development of artificial tissues. With the help of U-FAB, and other bioprinting technologies, CLECELL company has created respiratory epithelium artificial tissue which will help to prevent infection and tissue injury through the use of the mucociliary elevator. This pandemic has not only affected the well-being of people, but has also affected the economy, and various other healthcare infrastructures worldwide. This has severely disrupted the medical devices and pharmaceutical supply chains across the world. In such critical situation, various 3D bioprinting companies have created a global movement to supply emergency medical equipment such as ventilators, and personal protection equipment (PPE), to the healthcare workers.

North America held the highest share of the market, accounting for about 32.4% of the market share in 2020. Increasing adoption of 3D bioprinting for the production of medical products is expected to be one of the major factors contributing to market growth in this region. Whereas, Asia Pacific is anticipated to witness technological developments in pharmaceutical and biopharmaceutical sectors.

Request a free sample copy or view report summary: 3D Bioprinting Market Report

3D Bioprinting Market Report Highlights

• The medical segment accounted for the largest revenue share of 36.2% in 2020 due to the increasing investment made in R&D
• The magnetic levitation segment is anticipated to witness the highest CAGR of 17.0% over the forecast period due to technological development and increasing adoption of magnetic levitation technique by various innovators
• North America dominated the market in 2020 and accounted for the largest revenue share of 32.4%. Growing government expenditure on healthcare industry is one of the major factors driving the market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-3d-bioprinting-market

3D Bioprinting Market Segmentation

Grand View Research has segmented the global 3D bioprinting market on the basis of technology, application, and region:

3D Bioprinting Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Inkjet-based
• Magnetic Levitation
• Syringe-based
• Laser-based
• Others

3D Bioprinting Application Outlook (Revenue, USD Million, 2016 - 2028)

• Medical
  • Tissue and organ generation
  • Medical pills
  • Prosthetics and implants
• Dental
• Biosensors
• Consumer/Personal Product Testing
• Bioinks
• Food and Animal Product

3D Bioprinting Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of 3D Bioprinting Market

• Envisiontec, Inc.
• Organovo Holdings, Inc.
• Inventia Life Science PTY LTD
• Poietis
• Vivax Bio, LLC
• Allevi
• Cyfuse Biomedical K.K.
• 3D Bioprinting Solutions
• Cellink Global
• Regemat 3D S.L.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

3D Bioprinting Market Analysis ,Industry Growth And Future Scope: Grand View Research Inc.

 3D Bioprinting Market Growth & Trends

The global 3D bioprinting market size is expected to reach USD 4.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.8% from 2021 to 2028. Rising cases of COVID-19 and increasing prevalence of chronic diseases are some of the major factors contributing towards market growth.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 12, 2021, more than 91.5 million cases of COVID-19 were reported globally, with more than 1,956,880 deaths, across the globe. This pandemic has fast tracked the development of vaccine and drug testing. There are currently more than 50 COVID-19 vaccine candidates in trials.

In the meantime, various 3D bioprinting companies are focused on research and development of artificial tissues. With the help of U-FAB, and other bioprinting technologies, CLECELL company has created respiratory epithelium artificial tissue which will help to prevent infection and tissue injury through the use of the mucociliary elevator. This pandemic has not only affected the well-being of people, but has also affected the economy, and various other healthcare infrastructures worldwide. This has severely disrupted the medical devices and pharmaceutical supply chains across the world. In such critical situation, various 3D bioprinting companies have created a global movement to supply emergency medical equipment such as ventilators, and personal protection equipment (PPE), to the healthcare workers.

North America held the highest share of the market, accounting for about 32.4% of the market share in 2020. Increasing adoption of 3D bioprinting for the production of medical products is expected to be one of the major factors contributing to market growth in this region. Whereas, Asia Pacific is anticipated to witness technological developments in pharmaceutical and biopharmaceutical sectors.

Request a free sample copy or view report summary: 3D Bioprinting Market Report

3D Bioprinting Market Report Highlights

• The medical segment accounted for the largest revenue share of 36.2% in 2020 due to the increasing investment made in R&D
• The magnetic levitation segment is anticipated to witness the highest CAGR of 17.0% over the forecast period due to technological development and increasing adoption of magnetic levitation technique by various innovators
• North America dominated the market in 2020 and accounted for the largest revenue share of 32.4%. Growing government expenditure on healthcare industry is one of the major factors driving the market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-3d-bioprinting-market

3D Bioprinting Market Segmentation

Grand View Research has segmented the global 3D bioprinting market on the basis of technology, application, and region:

3D Bioprinting Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Inkjet-based
• Magnetic Levitation
• Syringe-based
• Laser-based
• Others

3D Bioprinting Application Outlook (Revenue, USD Million, 2016 - 2028)

• Medical
  • Tissue and organ generation
  • Medical pills
  • Prosthetics and implants
• Dental
• Biosensors
• Consumer/Personal Product Testing
• Bioinks
• Food and Animal Product

3D Bioprinting Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of 3D Bioprinting Market

• Envisiontec, Inc.
• Organovo Holdings, Inc.
• Inventia Life Science PTY LTD
• Poietis
• Vivax Bio, LLC
• Allevi
• Cyfuse Biomedical K.K.
• 3D Bioprinting Solutions
• Cellink Global
• Regemat 3D S.L.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

In Vitro Diagnostics Market Growth in the Coming Years

 In Vitro Diagnostics Market Growth & Trends

The global in vitro diagnostics market size is expected to reach USD 113.9 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.5% from 2021 to 2027. The growth is driven by the growing geriatric population and technological advancements in diagnostics that are supporting its adoption.

Technological advancements in terms of accuracy, portability, and cost-effectiveness are expected to be one of the high impact rendering drivers of this market. For instance, in June 2017, Agena Bioscience launched the MassARRAY system integrated with CHIP Prep Module in Europe. The system was marketed as a CE-IVD product under Directive 98/79/EC. Moreover, Real-Time Polymerase Chain Reaction (qPCR) is one of the fastest-growing application segments of the in vitro diagnostics (IVD) market.

The IVD market is highly competitive in nature. Consequently, manufacturers are required to improvise products in terms of specificity, accuracy, precision, speed, and other parameters, in order to gain an advantage over previously marketed products.

A steady rise in consumer awareness about diagnosing infectious diseases and increasing disease prevalence, especially in developing and under-developed countries, are driving the market penetration of the products. For instance, in February 2019, Abbott received CE Mark for DETERMINE HBSAG 2 test for detection and diagnosis of hepatitis B surface antigen.

Organizations promote funding to support R&D and product development exercises pertaining to clinical diagnostics. For instance, Vela Diagnostics received USD 225,000 as Biomedical Advanced Research and Development Authority (BARDA) fund to develop COVID-19 tests. Moreover, the introduction of the American Health Care Act of 2017 is expected to improve the healthcare of the U.S. Rising government initiatives pertaining to the importance of IVD will fuel market growth.

The presence of effective technologies such as molecular diagnostics is expected to reduce the threat of substitutes. Moreover, their contribution in the field of genetic testing is of paramount importance and, therefore, experience a low threat of substitutes. However, high prices of these tests are expected to encourage patients to shift to external substitutes.

Major players in the market are Roche Diagnostics; Becton Dickinson; Abbott Laboratories; Siemens; and bioMerieux, which are well-established. Therefore, local companies and new organizations have little scope to enter the market and ensure sustainability. However, companies such as Danaher Corporation and Hologic have successfully excelled in the market through mergers and acquisitions. The seed capital required is high.

Request a free sample copy or view report summary: In Vitro Diagnostics Market Report 

In Vitro Diagnostics Market Report Highlights

• Molecular diagnostics is expected to witness the fastest growth over the forecast period
• High use of reagents in IVD testing, high demand for over-the-counter diagnostic tests, and increase in adoption of these tests in nonmedical facilities, such as home, are some of the factors that are driving the growth, providing it a clinical advantage over other IVD tests
• Reagents held the largest market share in 2020 owing to the increasing demand for genetic testing and availability of technologically advanced cancer diagnostic tests in countries with unmet clinical needs, such as India and Middle East & Africa
• The growing availability of CE-IVD certified kits globally to diagnose and screen patients during epidemic situations is expected to boost the growth of reagents and instruments segments
• Key players are updating their range of testing options for qPCR instruments by undertaking R&D initiatives for the development of kits that target emerging diseases, or by entering into agreements with other kit manufacturing companies

Access Press Release@ https://www.grandviewresearch.com/press-release/global-in-vitro-diagnostics-market

In Vitro Diagnostics Market Segmentation

Grand View Research has segmented the global in-vitro diagnostics market based on the product, technology, application, end-use, and region:

In Vitro Diagnostics Product Outlook (Revenue, USD Million, 2016 - 2027)

• Instruments
• Reagents
• Services

In Vitro Diagnostics Technology Outlook (Revenue, USD Million, 2016 - 2027)

• Immunoassay
  • Instruments
  • Reagents
  • Services
• Hematology
  • Instruments
  • Reagents
  • Services
• Clinical Chemistry
  • Instruments
  • Reagents
  • Services
• Molecular Diagnostics
  • Instruments
  • Reagents
  • Services
• Coagulation
  • Instruments
  • Reagents
  • Services
• Microbiology
  • Instruments
  • Reagents
  • Services
• Others
  • Instruments
  • Reagents
  • Services

In Vitro Diagnostics Application Outlook (Revenue, USD Million, 2016 - 2027)

• Infectious Disease
• Diabetes
• Oncology
• Cardiology
• Nephrology
• Autoimmune Disease
• Drug testing
• Others

In Vitro Diagnostics End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Hospitals
• Laboratories
• Home Care
• Others

In Vitro Diagnostics Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Argentina
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of In Vitro Diagnostics Market

• Abbott
• Danaher
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Becton, Dickinson and Company
• Siemens Healthineers AG
• QIAGEN
• Quidel Corporation
• Hoffmann-La Roche AG
• Sysmex Corporation
• Charles River Laboratories International, Inc.
• Quest Diagnostics
• Agilent Technologies

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biosensors Market Expected To Propel Industry Growth By Size ,Share And Forecast To 2028: Grand View Research Inc.

 

Biosensors Market Growth & Trends

The global biosensors market size is anticipated to reach USD 41.8 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.9% from 2021 to 2028. The rising prevalence of chronic conditions such as diabetes and obesity and the growing demand for early and accurate detection of any associated condition are the key driving factors for the market.

As per the WHO report, in 2016 over 1.9 billion individuals were overweight, out of which nearly 650.0 million were obese. This has increased the sales of testing and monitoring kits used as medical sensors in the home as well as healthcare settings, thus, boosting the market growth.

Furthermore, the outbreak of COVID-19 has drastically spurred the demand for point-of-care testing devices. FDA is giving fast-track approvals to the companies owing to the shortage of these devices globally. For instance, in May 2020, Philips secured 510k FDA clearance for its wearable biosensor, which helps in managing confirmed and suspected cases of COVID-19 in hospitals, promoting biosensors technology and product development.

Moreover, rapid technological advancements are expected to be a significant factor for market growth over the forecast period. For instance, in June 2020, Abbott received the U.S. FDA clearance for its next-generation, integrated glucose monitor system- FreeStyle Libre 2 intended to measure diabetes in individuals aged 4 years and above and has an optional real-time alarm.               

Request a free sample copy or view report summary: Biosensors Market Report

Biosensors Market Report Highlights

• On the basis of application, the medical segment dominated the market in 2020 with a revenue share of 66.6%. The device is considered an essential tool in the detection and monitoring of a wide range of medical conditions, such as diabetes and cancer
• Based on technology, the electrochemical segment dominated the market in 2020 with a revenue share of 70.9% owing to its widespread applications for analysis in biochemical and biological processes
• The home healthcare diagnostics segment is expected to witness the fastest growth rate over the forecast period owing to the high prevalence of chronic disease globally
• North America dominated the market in 2020 with a revenue share of 39.9% owing to the presence of a highly developed healthcare infrastructure and favorable reimbursement policies in this region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biosensors-market

Biosensors Market Segmentation

Grand View Research has segmented the global biosensors market on the basis of application, technology, end-use, and region:

Biosensors Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Thermal
• Electrochemical
• Piezoelectric
• Optical

Biosensors Application Outlook (Revenue, USD Million, 2016 - 2028)

• Medical
  • Cholesterol
  • Blood Glucose
  • Blood Gas Analyzer
  • Pregnancy Testing
  • Drug Discovery
  • Infectious Disease
• Food Toxicity
• Bioreactor
• Agriculture
• Environment
• Others

Biosensors End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Home Healthcare Diagnostics
• PoC Testing
• Food Industry
• Research Laboratories
• Security and Biodefense

Biosensors Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Belgium
  • Switzerland
  • Netherlands
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey

List of Key Players of Biosensors Market

• AZUR Environmental
• Abbott Laboratories
• Biosensor BV
• Bayer AG
• Cranfield Biotechnology Centre
• Pinnacle Technologies Inc.
• DuPont Biosensor Materials
• Ercon, Inc.
• EG & IC Sensors, Inc.
• Johnson & Johnson
• Innovative Biosensors Inc.
• LifeScan, Inc.
• Strategic Diagnostics
• Sysmex Corporation
• Molecular Devices Corp.
• QTL Biosystems
• Roche Diagnostics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biotechnology Market is Expected to Enhance $2.44 Trillion Revenue By 2028: Grand View Research Inc.

 

Biotechnology Market Growth & Trends

The global biotechnology market size is expected to reach USD 2.44 trillion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 15.83% from 2021 to 2028. The factors driving the market include favorable government policies, the launch of new and advanced products, robust investment in the biotechnology sector, and rising demand for synthetic biology.

Robust funding through alliance investment in start-up biotechnology companies for adopting new and advanced products is contributing to market growth. For instance, in February 2021, Illumina, Inc. invested in nine new genomics companies through Illumina Accelerator in 4 start-ups in the U.K. and 5 start-ups in the U.S. The companies include MultiplAI Health LTD.; BiotaX Labs LTD.; Mitra Bio Limited; Broken String Biosciences Limited; Flightpath Biosciences, Inc.; Doloromics Inc.; Oshun Medical Inc.; Parallel Health Inc.; and Rubik Therapeutics, Inc. Illumina Accelerator is an initiative through which selected startups can access to seed investment, genomics expertise, and Illumina sequencing systems and reagents and seek business guidance.

The bioinformatics application segment is expected to expand at the fastest CAGR from 2021 to 2028 owing to the increasing adoption of these tools for analyzing complex sequencing data. By technology, nanobiotechnology is expected to expand at a lucrative growth rate of 16.8% over the forecast period owing to the growing focus on nanotechnologies for efficient drug delivery and increasing research using this technology.

Supportive government initiatives are significantly contributing to market growth. For instance, in September 2020, the Government of India supported research institutes in agriculture biotechnology, including organic farming. Since the last 3 years, around USD 42.67 million had been invested to support this endeavor.

Moreover, the emergence of the SARS-COV-2 infection is driving the market. Companies are developing new solutions for combating the pandemic situation. For instance, in December 2020, Thermo Fisher Scientific Inc. announced CE-marking for TaqPath COVID-19 that can be used to perform in-vitro diagnosis of SARS-CoV-2, respiratory syncytial virus (RSV) A/B, and influenza A/B infections. The new kit will help in the detection and differentiation between diseases that have similar clinical symptoms.

Request a free sample copy or view report summary: Biotechnology Market Report

Biotechnology Market Report Highlights

• The health application segment accounted for the largest share of 48.64% in 2020 owing to the COVID-19 impact, prevalence of diseases, increasing focus on the development of regenerative medicines, and improving healthcare infrastructure
• The DNA sequencing technology segment held the second-largest share in 2020 owing to its growing penetration in the development of precision medicines
• North America held the largest share of 44.19% in 2020. Companies operating in the region are launching advanced solutions to cater to the needs of the biotechnology industry
• For instance, in February 2021, Waters Corporation launched Waters ACQUITY PREMIER Solution. It is a next-generation liquid chromatography solution for improving analytical data quality
• Asia Pacific is expected to expand at the fastest CAGR of 16.8% from 2021 to 2028 owing to favorable government initiatives and changes in drug approval regulations in India and China

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biotechnology-market

Biotechnology Market Segmentation

Grand View Research has segmented the global biotechnology market on the basis of technology, application, and region:

Biotechnology Technology Outlook (Revenue, USD Billion, 2017 - 2028)

• Nanobiotechnology
• Tissue Engineering And Regeneration
• DNA Sequencing
• Cell-based Assays
• Fermentation
• PCR Technology
• Chromatography
• Others

Biotechnology Application Outlook (Revenue, USD Billion, 2017 - 2028)

• Health
• Food & Agriculture
• Natural Resources & Environment
• Industrial Processing
• Bioinformatics
• Others

Biotechnology Regional Outlook (Revenue, USD Billion, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Biotechnology Market

• AstraZeneca
• Gilead Sciences, Inc.  
• CELGENE CORPORATION
• Biogen
• Abbott
• Amgen Inc.
• Novo Nordisk A/S
• Merck & Co.
• Johnson & Johnson Services, Inc.
• Novartis AG
• Sanofi
• Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• Lonza

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.